CNP-201 in Subjects With Peanut Allergy
Public ClinicalTrials.gov record NCT05250856. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1b/2a Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of CNP-201 in Subjects Ages 16-55 With Peanut Allergy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is a Phase 1b/2a clinical trial to assess the safety, tolerability, and pharmacodynamics of multiple ascending doses (Escalation Phase) of CNP-201 with the goal of identifying a safe and tolerable dose level to be evaluated further in a larger number of subjects (Expansion Phase).
Study identification
- NCT ID
- NCT05250856
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 15 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 16 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 14, 2022 (Actual)
- Primary completion
- Dec 12, 2023 (Actual)
- Completion
- Dec 12, 2023 (Actual)
- Last update posted
- Dec 20, 2023
2022 – 2023
United States locations
- U.S. sites
- 17
- U.S. states
- 11
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| AllerVie Clinical Research | Birmingham | Alabama | 35209 | — |
| Long Beach Clinical Trials, LLC | Long Beach | California | 90806 | — |
| Southern California Research | Mission Viejo | California | 92691 | — |
| Allergy & Asthma Medicaal Group and Research Center | San Diego | California | 60062 | — |
| Rush University Medical Center | Chicago | Illinois | 60612 | — |
| Sneeze, Wheeze and Itch Associates, LLC | Normal | Illinois | 61761 | — |
| Meridian Clinical Research. LLC | Overland Park | Kansas | 66210 | — |
| Institute for Asthma & Allergy | Chevy Chase | Maryland | 20815 | — |
| Aventiv Research, Inc | Columbus | Ohio | 43213 | — |
| Vital Prospects Clinica Research Institute | Tulsa | Oklahoma | 74136 | — |
| National Allergy and Asthma Research, LLC | North Charleston | South Carolina | 29420 | — |
| Allergy Partners of North Texas Research | Dallas | Texas | 75230 | — |
| Pharmaceutical Research & Consulting, Inc | Dallas | Texas | 75231 | — |
| Western Sky Medical Research | El Paso | Texas | 79903 | — |
| Tranquil Clinical and Research Consulting Services | Houston | Texas | 77598 | — |
| Clinical Research Partners | Richmond | Virginia | 23226 | — |
| Seattle Allergy & Asthma Research Institute | Seattle | Washington | 98115 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05250856, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 20, 2023 · Synced Nov 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05250856 live on ClinicalTrials.gov.